President & CEO of Laboratory Corp Of America Holdings (NYSE:LH) David P King sold 49,966 shares of LH on 05/23/2018 at an average price of $175.37 a share. The total sale was $8.8 million.
Laboratory Corp of America Holdings is a healthcare diagnostics company. It is engaged in providing comprehensive clinical laboratory and end-to-end drug development services. It operates in two segments: LabCorp Diagnostics and Covance Drug Development. Laboratory Corp of America Holdings has a market cap of $18.73 billion; its shares were traded at around $183.11 with a P/E ratio of 15.21 and P/S ratio of 1.74. Laboratory Corp of America Holdings had annual average EBITDA growth of 7.60% over the past ten years. GuruFocus rated Laboratory Corp of America Holdings the business predictability rank of 5-star.
CEO Recent Trades:
President & CEO David P King sold 49,966 shares of LH stock on 05/23/2018 at the average price of $175.37. The price of the stock has increased by 4.41% since.For the complete insider trading history of LH, click here
.
No comments:
Post a Comment